Zobrazeno 1 - 10
of 432
pro vyhledávání: '"Han Chu, Lee"'
Autor:
Jiwon Yang, Won-Mook Choi, Hyung-Don Kim, Jonggi Choi, Changhoon Yoo, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
Publikováno v:
Liver Cancer, Pp 1-13 (2024)
Introduction: Proteinuria presents a challenging complication during systemic therapy for hepatocellular carcinoma (HCC). This study aims to identify risk factors for proteinuria in patients with HCC treated with atezolizumab plus bevacizumab (Atezo/
Externí odkaz:
https://doaj.org/article/50ebc3282c30430f880af6215c6d0d4d
Autor:
Jiwon Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Deok-Bog Moon, Dong-Hwan Jung, Jonggi Choi
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 178-191 (2024)
Backgrounds/Aims This study aimed to compare the outcomes of liver resection (LR) and transarterial chemoembolization (TACE) in patients with multinodular hepatocellular carcinoma (HCC) within the Milan criteria who were not eligible for liver transp
Externí odkaz:
https://doaj.org/article/c22de94c68384f86b3e2181885101dfc
Autor:
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Publikováno v:
Gut and Liver, Vol 18, Iss 1, Pp 147-155 (2024)
Background/Aims: With the wide application of direct-acting antivirals (DAAs) for hepatitis C virus infection, the number of patients achieving a sustained virologic response (SVR) will continue to increase. However, no consensus has been achieved on
Externí odkaz:
https://doaj.org/article/0af79f380fa44c0a8121bfe0fa40205f
Autor:
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 1, Pp 49-63 (2024)
Background/Aims Tenofovir disoproxil fumarate (TDF) is known to have a lipid-lowering effect. This is in contrast to tenofovir alafenamide (TAF), which has a lipid-neutral effect. Therefore, concerns have been raised as to whether these differences a
Externí odkaz:
https://doaj.org/article/d76e56c964ad4ba1b72800a944befeeb
Autor:
Dongsub Jeon, Hye Ryeong Cha, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Seung Won Lee, Won-Mook Choi
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102300- (2023)
Summary: Background: The majority of patients with hepatocellular carcinoma (HCC) following hepatic resection experience tumor recurrence. Statin use is associated with a reduced risk of HCC development; however, the association between statin use an
Externí odkaz:
https://doaj.org/article/aa44651b2dbf4da6b860df3d8135fec2
Autor:
Sujin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Publikováno v:
Journal of Liver Cancer, Vol 23, Iss 1, Pp 177-188 (2023)
Background/Aim The Barcelona Clinic Liver Cancer (BCLC) guidelines recommend systemic therapy as the only first-line treatment for patients with BCLC stage C hepatocellular carcinoma (HCC) despite its heterogeneity of disease extent. We aimed to iden
Externí odkaz:
https://doaj.org/article/53ea0306484a42b1b1f5e8d745c96b0e
Autor:
Jonggi Choi, Jina Park, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung
Publikováno v:
Gut and Liver, Vol 16, Iss 6, Pp 964-975 (2022)
Background/Aims: The care cascade for hepatitis C virus (HCV) infection is impeded by multiple barriers, including suboptimal anti-HCV testing, link to care, and diagnosis. We explored the changes in the care cascade of HCV for the past 20 years and
Externí odkaz:
https://doaj.org/article/91333551f39a437da0228ea3f134f9e2
Autor:
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok-Bog Moon, Ki-Hoon Kim, Tae Won Kim, Jeong Seok Lee, Richard S. Finn, June-Young Koh, Changhoon Yoo
Regorafenib plus nivolumab (RegoNivo) combination has shown promising anti-cancer activity in multiple cancer types. REBNOBATE trial is a single-arm multicenter phase 2 trial of first-line RegoNivo in patients (pts) with uHCC (NCT04310709). Here we r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e24ad3eff16aefcb685092da825f8c7
Autor:
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jin-hong Park, Sang Min Yoon
Publikováno v:
Journal of Liver Cancer, Vol 22, Iss 2, Pp 136-145 (2022)
Background/Aim We aimed to investigate the efficacy and safety of stereotactic body radiation therapy (SBRT) in elderly patients with small hepatocellular carcinomas (HCC). Methods Eighty-three patients (89 lesions) with HCC who underwent SBRT betwee
Externí odkaz:
https://doaj.org/article/80866693644842a2a2871315878659da
Autor:
Jihye Lim, Seungbong Han, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Dong Hwan Jung, Sung‐Gyu Lee, Ki‐Hun Kim, Jonggi Choi
Publikováno v:
Hepatology Communications, Vol 6, Iss 7, Pp 1689-1698 (2022)
Abstract Selecting an optimal donor for living donor liver transplantation is crucial for the safety of both the donor and recipient, and hepatic steatosis is an important consideration. We aimed to build a prediction model with noninvasive variables
Externí odkaz:
https://doaj.org/article/ffe00f853b70486c89b8c9766b516114